
The Community of Madrid sends eight fire crews and another eight from Summa 112 to collaborate in the rescue
The Community of Madrid sends health and fire resources to Urda (Toledo) after a train accident, whose main police hypothesis points to human error.
AI-generated summary
A train accident occurred in the Toledo municipality of Urda, generating the mobilization of emergency services.
The Community of Madrid has sent eight crews and firefighters and another eight from Summa 112 to help in the rescue and care efforts.
Train accident in Toledo, live | Human error, the main hypothesis of the train accident according to the Government
The hospitals of the Community of Madrid and their health resources are put at the service of Castilla-La Mancha to care for and transport those injured in the train accident in the Toledo municipality of Urda. Eight fire crews and another eight from Summa 112 have left the region to help in the rescue and assistance efforts.

Hundreds of people crowd the Toledo University Hospital to donate blood after a train accident that has caused 64 deaths. Citizens from various locations come en masse to help the victims of the accident.

Women in Spain suffer from shortages of hormonal treatments for menopause, forcing them to look for drugs in Portugal or change medication, in a crisis that also affects trans women and assisted reproduction.

Medetomidine, a veterinary sedative known as 'rhino tranq', is on the rise in the US and arrives in Europe mixed with opioids and stimulants, alerting health authorities due to its extreme potency and deadly effects.

Shamonda virus, an orthobunavirus until now exclusive to livestock animals and transmitted by insects, has been identified for the first time in a human in France, a deceased man with severe immunosuppression.

France is investigating the first human case of death in which the Shamonda virus is the main suspect, a pathogen transmitted by midges of the Culicoides genus that mainly affects livestock.

The ESMO congress in Madrid presented the results of the INTerpath-001 trial. The personalized messenger RNA vaccine, combined with pembrolizumab, reduced the risk of relapse or death by 42% in patients with high-risk melanoma after surgery.